Medical Device Network on MSN
JPM26: Boston Scientific acquires Penumbra in $14.5bn deal
Boston will inherit products, including Penumbra’s Lightning thrombectomy systems, to advance its vascular care provision.
Boston Scientific Corporation will acquire Penumbra for $14.5B in cash and stock, aiming to close the deal this year. BSX expands into high-growth neurovascular and peripheral thrombectomy segments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results